Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,528 | 180,070 | 208,166 | 164,594 | 163,970 |
| Receivables | 603,544 | 552,378 | 566,881 | 560,563 | 527,464 |
| Inventories | 382,400 | 377,756 | 391,564 | 392,584 | 395,987 |
| Other current assets | 267,603 | 303,623 | 310,444 | 244,616 | 230,192 |
| TOTAL | $1,454,075 | $1,413,827 | $1,477,055 | $1,362,357 | $1,317,613 |
| Non-Current Assets | |||||
| PPE Net | 740,382 | 747,380 | 739,437 | 739,677 | 717,624 |
| Intangibles | 516,854 | 523,847 | 528,441 | 518,217 | 514,894 |
| Other Non-Current Assets | 674,186 | 665,705 | 641,779 | 710,543 | 663,558 |
| TOTAL | $1,931,422 | $1,936,932 | $1,909,657 | $1,968,437 | $1,896,076 |
| Total Assets | $3,385,497 | $3,350,759 | $3,386,712 | $3,330,794 | $3,213,689 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 149,997 | 74,995 | 149,997 | 74,994 | 170,929 |
| Accounts payable and accrued liabilities | 129,974 | 110,408 | 122,265 | 116,585 | 120,096 |
| Accrued Expenses | 453,552 | 530,147 | 488,856 | 416,977 | 490,688 |
| TOTAL | $1,299,851 | $1,148,814 | $1,251,811 | $1,223,880 | $1,136,213 |
| Non-Current Liabilities | |||||
| Long Term Debt | 299,854 | 374,842 | 374,825 | 449,812 | 449,799 |
| Deferred Revenues | 36,328 | 35,264 | 35,693 | 36,324 | 35,000 |
| Other Non-Current Liabilities | 152,781 | 157,678 | 164,115 | 164,425 | 144,735 |
| TOTAL | $529,543 | $596,562 | $573,715 | $648,087 | $629,463 |
| Total Liabilities | $1,829,394 | $1,745,376 | $1,825,526 | $1,871,967 | $1,765,676 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,883 | 79,624 | 79,851 | 80,005 | 80,422 |
| Common Shares | 10,850 | 10,837 | 10,830 | 10,804 | 10,792 |
| Retained earnings | 6,670,348 | 6,391,902 | 6,143,714 | 5,869,104 | 5,575,115 |
| Other shareholders' equity | -59,174 | -63,106 | -67,145 | -70,491 | -84,507 |
| TOTAL | $1,556,103 | $1,605,383 | $1,561,186 | $1,458,827 | $1,448,013 |
| Total Liabilities And Equity | $3,385,497 | $3,350,759 | $3,386,712 | $3,330,794 | $3,213,689 |